Aridis Pharmaceuticals Inc. announced the appointment of former Gilead Sciences executive Craig Gibbs, Ph.D., MBA, to its Board of Directors. Dr. Gibbs currently serves on the Board of Directors of Tobira Therapeutics and is an advisor to several biotechnology companies and venture capital firms.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 USD | +8.89% |
|
-21.57% | -14.41% |
Jun. 24 | Aridis Pharmaceuticals, Inc. Provides Corporate Update on Recent Developments | CI |
Jun. 24 | Aridis Pharmaceuticals, Inc. announced that it expects to receive $0.299 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-14.41% | 3.2M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- ARDS Stock
- News Aridis Pharmaceuticals, Inc.
- Aridis Pharmaceuticals Inc. Appoints Craig Gibbs to Board of Directors